Abstract
Cyclin-dependent kinases (CDK) 4/6 inhibitors, namely abemaciclib, palbociclib, and ribociclib, interfere with cell cycle progression, induce cell sen......
小提示:本篇文献需要登录阅读全文,点击跳转登录